Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (48)

2023

  1. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

    Nature Genetics, Vol. 55, Núm. 12, pp. 2065-2074

  2. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

    American Journal of Human Genetics, Vol. 110, Núm. 7, pp. 1200-1206

2022

  1. Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer Status

    Cancers, Vol. 14, Núm. 8

  2. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

    Prostate cancer and prostatic diseases, Vol. 25, Núm. 4, pp. 755-761

  3. Small static radiosurgery field dosimetry with small volume ionization chambers

    Physica Medica, Vol. 97, pp. 66-72

2021

  1. Common Susceptibility Loci for Male Breast Cancer

    Journal of the National Cancer Institute, Vol. 113, Núm. 4, pp. 453-461

  2. Marital status and prostate cancer incidence: a pooled analysis of 12 case–control studies from the PRACTICAL consortium

    European Journal of Epidemiology, Vol. 36, Núm. 9, pp. 913-925

  3. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0)

    Nature Genetics

  4. Quality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: The CAVIDIOR study

    Future Oncology, Vol. 17, Núm. 8, pp. 943-954

  5. Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments

    Journal of Clinical Pharmacy and Therapeutics, Vol. 46, Núm. 3, pp. 724-730

  6. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    Nature Genetics, Vol. 53, Núm. 1, pp. 65-75

2020

  1. Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

    Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12

2019

  1. A volumetric delta TCP tool to quantify treatment outcome effectiveness based on biological parameters and different dose distributions

    IFMBE Proceedings

  2. An EGS Monte Carlo model for Varian TrueBEAM treatment units: Commissioning and experimental validation of source parameters

    Physica Medica, Vol. 64, pp. 81-88

  3. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8)

    Nature Genetics

  4. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

    Nature Communications

  5. Novel common genetic susceptibility loci for colorectal cancer

    Journal of the National Cancer Institute, Vol. 111, Núm. 2, pp. 146-157

2018

  1. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Nature Genetics, Vol. 50, Núm. 7, pp. 928-936

  2. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group

    Clinical and Translational Oncology, Vol. 20, Núm. 11, pp. 1467-1473

  3. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

    Nature Communications, Vol. 9, Núm. 1